Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
LPHN3 encodes a member of the latrophilin subfamily of G-protein coupled receptors (GPCR). Zusätzlich bieten wir Ihnen LPHN3 Proteine (7) und LPHN3 Kits (6) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 39 products:
Bat Polyclonal LPHN3 Primary Antibody für IHC (p) - ABIN270533
Arcos-Burgos, Jain, Acosta, Shively, Stanescu, Wallis, Domené, Vélez, Karkera, Balog, Berg, Kleta, Gahl, Roessler, Long, Lie, Pineda, Londoño, Palacio, Arbelaez, Lopera, Elia, Hakonarson, Johansson et al.: A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. ... in Molecular psychiatry 2010
An ultraconserved brain-specific (zeige CALY Antikörper) enhancer within LPHN3 is associated with ADHD susceptibility.
Associations between LPHN1 (zeige LPHN1 Antikörper) and LPHN3 polymorphisms and severity of bronchial hyper-responsiveness in asthmatics were conducted; however, no associations were found.
Results suggest that UNC5 and LPHN3 can simultaneously bind to FLRT3 (zeige FLRT3 Antikörper), forming a trimeric complex, and that FLRT3 (zeige FLRT3 Antikörper) may form transsynaptic complexes with both LPHN3 and UNC5.
LPHN3 confers ADHD susceptibility, and moderates methylphenidate treatment response in children and adolescents with ADHD.
Study examined the association between the LPHN3 rs6551665 A/G polymorphism and Attention deficit hyperactivity disorder (ADHD) in Korea; samples used in the study consisted of 150 ADHD children and 322 controls; ADHD children appeared to have a surplus of GG genotype, studies with larger sample sizes needed.
genetic association studies in Germany: Data suggest that, within a sample of patients with attention deficit disorder hyperactivity, SNPs in LPHN3 gene impacts behavioral and neurophysiological measures of cognitive response control.
Increased LPHN3 mRNA expression levels correlated with axillary-node metastasis in breast cancer.
The influence of LPHN3 genotype on attention deficit-hyperactivity disorder (ADHD) and addiction is mediated through alterations in transgenic monoamine signaling.
A two-locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long-term outcome.
This study identifying loci for aADHD and led to the identification of LPHN3 as novel genes associated with ADHD across the lifespan.
Data show that Unc5 cell guidance receptor Unc5D (zeige UNC5D Antikörper) controls Latrophilin3 (LPHN3)-FLRT protein FLRT2 (zeige FLRT2 Antikörper)-mediated cell adhesion.
The crystal structure of the OLF/FLRT3 (zeige FLRT3 Antikörper) complex shows that LPHN3-OLF in the closed state binds with high affinity to the concave face of FLRT3 (zeige FLRT3 Antikörper)-LRR with a combination of hydrophobic and charged residues.
Null mutant Lphn3 mice had a hyperactive phenotype in the open field test, independent of sex, and were more sensitive to locomotor stimulation.
This gene encodes a member of the latrophilin subfamily of G-protein coupled receptors (GPCR). Latrophilins may function in both cell adhesion and signal transduction. In experiments with non-human species, endogenous proteolytic cleavage within a cysteine-rich GPS (G-protein-coupled-receptor proteolysis site) domain resulted in two subunits (a large extracellular N-terminal cell adhesion subunit and a subunit with substantial similarity to the secretin/calcitonin family of GPCRs) being non-covalently bound at the cell membrane.
, calcium-independent alpha-latrotoxin receptor 3
, latrophilin homolog 3 (cow)
, lectomedin 3
, calcium-independent alpha-latrotoxin receptor homolog 3